4502

How is 4502 doing right now?

In plain terms: 4502 is 15.8% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

4502 (Takeda Pharmaceutical Co.) is 15.8% below its historical peak. Tape reads in a moderate correction, with the last trade at $4,961. A drawdown of this depth is where patient buyers start paying attention. Historically the asymmetry begins to favor accumulation here, especially when paired with structural demand.

What history says at this drawdown

History at this drawdown level is well-populated for 4502 — 522 confirmed observations in the 20%-to-15% band. The Dipsern engine uses these to compute a rolling median rather than a mean, because medians are robust to the kind of fat tails you find in japanese stocks return distributions. The win rate (% of episodes that closed positive after 90 days) is shown in the segments table below.

What this means for 4502

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to 4502's own volatility history. Moderate corrections are the highest-information zone for the Dipsern signal: enough drawdown for mean-reversion to matter, not so much that fundamentals are likely broken. Watch the prediction-error column — if past signals at this level were accurate, the current one is more trustworthy.